OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Endocrinology Diabetes and Obesity is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	40
Obesity and infertility: a double whammy	34
Updates in thyroid healthcare delivery: advancing patient-centered care	34
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	33
Advances in assessment and treatment of bone, mineral and parathyroid disorders	32
Nutrition and thyroid disease	28
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	28
Editorial introduction	28
Beyond weight loss: tirzepatide as a dual GIP/GLP-1 receptor agonist for obstructive sleep apnea	26
Editorial introduction	26
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	24
Financial toxicity in thyroid cancer survivors	20
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	20
An update on bone in diabetes	20
Recent advances in anaplastic thyroid cancer management	20
Preventing type 1 diabetes development and preserving beta-cell function	19
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency	19
Editorial introduction	17
The use of anabolic agents in the treatment of osteoporosis: a clinical update	16
Update on fracture risk assessment in osteoporosis	16
Gastrointestinal hormones and regulation of gastric emptying	14
Interactions between antidiabetes medications and heart–brain axis	14
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	14
Fibrous dysplasia in children and its management	13
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	13

Epidemiologic changes in thyroid disease	12
Assisted reproductive technology outcomes and management considerations for people with epilepsy	12
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	12
Precision medicine in diabetes care	12
Long-acting amylin analogues for the management of obesity	12
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	12
A short history of saturated fat: the making and unmaking of a scientific consensus	11
Editorial introductions	11
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	11
The uncommon forms of congenital adrenal hyperplasia	11
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	11
Type 2 diabetes: a contemporary view from the Asian lens	11
Adrenal insufficiency and pregnancy	10
Novel techniques for assessment of bone tissue material properties	10
Glucocorticoid withdrawal syndrome: what to expect and how to manage	10
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation	10
Legislation, medicine, and politics: care for gender diverse youth	10
An update on investigation and management of renal bone disease	10
Editorial introductions	10
Time to cycle regularity and health risks	9
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	9
Editorial introductions	9
Editorial introductions	9
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	8
Indications for testosterone therapy in men	8
Microplastics, cardiometabolic risk, genetics and Alzheimer's disease	8
Multifactorial chylomicronemia syndrome	8
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective	8
The interaction between gut microbiome and bone health	8
Advanced imaging and theranostics in thyroid cancer	7
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?	7
Type 2 diabetes mellitus and cognitive function: understanding the connections	7
The psychosocial impact of thyroid cancer	7
Polygenic risk scores for the diagnosis and management of dyslipidemia	7
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome	7
Radiofrequency ablation (RFA) compared to observation for benign thyroid nodules: emerging considerations for judicious use	6
Gastrointestinal regulatory peptides	6
When history, law, and medicine intersect	6
Current challenges in Cushing's syndrome testing: blood, saliva, urine, or hair?	6
Editorial introductions	6
Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials	6
Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases	6
Predictors of cardiovascular risk in familial hypercholesterolemia	6
Editorial: New horizons for thyroid diseases: transformative changes and tailored care	5
Can artificial intelligence and wearable technologies transform diabetes foot health?	5
Potassium-competitive acid blockers and acid-related disorders	5
Bridging the LatinX community care gap	5
Skeletal health in diabetes	5
Prediabetes and skeletal health	5
Glutamic acid decarboxylase immunotherapy for type 1 diabetes	5

HDL functionality in type 1 and type 2 diabetes: new insights	5
Fracture prediction tools in diabetes	5
Mixed-methods research on androgen abuse – a review	5
Recent advances in the role of miRNAs in bone disease	5
The psychological dimension of obesity – an uncharted territory	4
Subclinical hyperthyroidism	4
Cardiovascular disease in metabolic-associated fatty liver disease	4
Preconception health optimization in women with polycystic ovary syndrome − how to find the time?	4
Cardiometabolic risk and therapeutic outcomes in mild autonomous cortisol secretion	4
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms	4
Bone marrow adiposity in diabetes and clinical interventions	4
The approaches and challenges in the management of differentiated thyroid carcinoma	4
Editorial introductions	4
Better care for women with polycystic ovary syndrome – a proposal for an international evidence based best practice framework to improve care	3
Overview of diabetes agents in cardiovascular disease: it takes an orchestra to play Tchaikovsky in symphony	3
Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?	3
Emerging treatment for congenital adrenal hyperplasia	3
The evolution of C-peptide's role in diabetes care	3
Update on management of paediatric dyslipidaemia	3
Hypoparathyroidism update	3
Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome	3
Health effects of androgen abuse: a review of the HAARLEM study	3
An update: maternal iodine supplementation, thyroid function tests, and child neurodevelopmental outcomes	3
Obesity during pregnancy: contemporary evidence and clinical implications	3
Editorial: Childhood endocrine and genetic disorders: improving adult outcomes	3
Differences in the management of thyroid nodules in children and adolescents as compared to adults	3
Glucagon-like peptide-1 receptor agonists and safety in the preconception period	3
Enteroendocrine cell differentiation and function in the intestine	2
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia	2
Editorial overview	2
Addressing genetic and environmental sources of cardiometabolic disease	2
Editorial introductions	2
Current perspectives on biomarkers in metabolic bone disease	2
Adjunctive diabetes therapies and cardiovascular protection in type 1 diabetes: tackling the challenging Tchaikovsky piece	2
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?	2
Effect of incretins on skeletal health	2
Molecular testing for indeterminate thyroid nodules: past, present, and future	2
Effect of GLP-1 receptor agonists on body composition	2
Editorial introductions	2
Editorial introduction	2
Selective progesterone receptor modulators and reproductive health	2
Mouse models of type 1 diabetes and their use in skeletal research	2
Use of calculated free testosterone in men: advantages and limitations	2
Under and overtreatment with thyroid hormone replacement during pregnancy	2
Editorial introduction	2
Molecular tools for diagnosing diseases of the adrenal cortex	2
Eicosapentaenoic acid vs. docosahexaenoic acid for the prevention of cardiovascular disease	2
Emerging concepts in the diagnosis and management of metabolically associated steatotic liver disease	2
Obesity-related glomerulopathy: a lesser known complication of obesity	2